Embryonic Intermediate Filaments, Nestin and Vimentin, Expression in the Spinal Cords of Rats with Experimental Autoimmune Encephalomyelitis.
- Author:
Tae Kyun SHIN
1
;
Yong Duk LEE
;
Ki Bum SIM
Author Information
1. Department of Veterinary Medicine, College of Agriculture and Life Sciences, Cheju National University, Jeju 690-756, South Korea. shint@cheju.cheju.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
autoimmune encephalomyelitis;
nestin;
vimentin;
astrocyte
- MeSH:
Animals;
Encephalomyelitis, Autoimmune, Experimental/*metabolism/pathology;
*Gene Expression Regulation;
Intermediate Filament Proteins/*metabolism;
*Nerve Tissue Proteins;
Rats;
Rats, Inbred Lew;
Spinal Cord/cytology/*metabolism/pathology;
Stem Cells/cytology;
Vimentin/*metabolism
- From:Journal of Veterinary Science
2003;4(1):9-13
- CountryRepublic of Korea
- Language:English
-
Abstract:
Intermediate filaments, including nestin and vimentin, are found in specific cell types in central nervous system (CNS) tissues, particularly immature glial cells and multipotent progenitor cells. In the present study, the expression patterns of nestin and vimentin in the spinal cords of rats with experimental autoimmune encephalomyelitis (EAE) and the response of cells containing filaments against acute autoimmune injury were examined by immunohistochemistry. Nestin immunostaining was only weakly detected in vascular endothelial cells but not in any cell types in the spinal cord in normal and adjuvant-immunized rats. At the peak stage of EAE, nestin-immunoreativity was recognized in some astrocytes in the gray matter and white matter. Vimentin was immunopositive in some astrocytes and macrophages in EAE lesions, while vimentin was normally detected in ependymal cells of central canals in the rat spinal cords.We postulate that normal animals may contain multipotent progenitor cells in the spinal cord parenchyma as well as in the subpial lesion and ependyma. Multipotent progenitor cells may activate to transform into necessary cells, including neurons, astrocytes or oligodendrocytes, depending on CNS needs. Appropriate control of progenitor cells in the injured CNS is an alternative choice for CNS remodeling.